Related Experiment Video
Updated: Feb 18, 2026

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Treatment for Livedoid Vasculopathy: A Systematic Review
Robert Micieli1, Afsaneh Alavi1,2
1Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Livedoid vasculopathy treatments, including anticoagulants and anabolic steroids, show favorable outcomes in case series. Further randomized trials are needed to establish effective therapies for this painful condition.
Area of Science:
- Dermatology
- Vascular Medicine
- Clinical Pharmacology
Background:
- Livedoid vasculopathy is a painful, ulcerative condition affecting the lower extremities.
- Current treatment options lack established efficacy and are based on limited evidence, such as case reports.
Purpose of the Study:
- To systematically review and synthesize available clinical data on treatments for livedoid vasculopathy.
- To assess the efficacy and outcomes of various therapeutic interventions.
Main Methods:
- A systematic literature review was conducted using Ovid MEDLINE and EMBASE databases.
- Included were English-language, peer-reviewed case series reports on livedoid vasculopathy treatments.
- References of retrieved articles were also searched.
Main Results:
- Twenty-nine case series involving 339 patients were analyzed.
- Treatments including anticoagulants, antiplatelets, anabolic steroids, and intravenous immunoglobulins showed favorable outcomes.
- Anticoagulants, as monotherapy, achieved a 98% favorable response rate in 63 patients.
Conclusions:
- Various treatments demonstrate varying degrees of success for livedoid vasculopathy.
- Randomized clinical trials are essential to establish evidence-based treatment guidelines.
More Related Videos
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Venous Thrombosis III: Interprofessional Care